← Leaderboards
Maurice Enriquez-Sarano
Mayo Clinic Coll Of Medicine, Rochester
$4,912,174
Attributed
$8,504,872
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$8,504,872 · 6
By mechanism
R01$5,251,583 · 2
UH3$2,018,643 · 1
UH2$1,151,147 · 1
M01$83,499 · 2
Top collaborators
- Jordan D Miller5 shared
- Hartzell V. Schaff5 shared
- Veronique L Roger4 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- S Vincent Rajkumar$8,690,866
- Veronique L Roger$16,345,856
- M E Sarano$0
Others in their field
Top investigators on “Ventricular Dysfunction”
- Leonardo Trasande · New York University School Of Medicine$50,897,521
- Robert H Jones · Duke University$27,263,568
- Richard W Gross · Washington University$24,299,353
- Daniel Patrick Kelly · University Of Pennsylvania$21,779,422
- David Couper · Univ Of North Carolina Chapel Hill$20,323,135
- Howard Minkoff · Suny Downstate Medical Center$19,270,705
Research focus
Ventricular DysfunctionMeetingsBiological MarkersMitral Valve InsufficiencyInsightEventAffectMeasurementRecruitment ActivityStagingFunctional DisorderEchocardiographyClinical TrialsAortic Valve StenosisAortic Valve ReplacementAngiotensin IiAortic Valve DisorderBone DensityAortic ValveAce InhibitorsBody SystemBloodAntioxidantsBiological Process
Grant awards (16)
Ventricular remodeling and heart failure after myocardial infarction: a community$742,525
R01 · FY2017 · HL
Ventricular remodeling and heart failure after myocardial infarction: a community$742,525
R01 · FY2016 · HL
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$969,945
UH3 · FY2015 · TR
Ventricular remodeling and heart failure after myocardial infarction: a community$731,387
R01 · FY2015 · HL
Ventricular remodeling and heart failure after myocardial infarction: a community$742,573
R01 · FY2014 · HL
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$681,374
UH3 · FY2014 · TR
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$367,324
UH3 · FY2014 · TR
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$163,310
UH2 · FY2014 · TR
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$987,837
UH2 · FY2013 · TR
MITRAL INSUFFICIENCY REDUCTION BY ANGIOTENSIN BLOCKADE$40,991
M01 · FY2005 · RR
BETA BLOCKADE IN MITRAL REGURGITATION$4,502
M01 · FY2005 · RR
ANGIOTENSIN-II BLOCKADE IN MITRAL REGURGITATION$499,427
R01 · FY2004 · HL
Mitral Insufficiency Reduction by Angiotensin Blockade$38,006
M01 · FY2004 · RR
ANGIOTENSIN-II BLOCKADE IN MITRAL REGURGITATION$629,466
R01 · FY2003 · HL
ANGIOTENSIN-II BLOCKADE IN MITRAL REGURGITATION$610,368
R01 · FY2002 · HL
ANGIOTENSIN-II BLOCKADE IN MITRAL REGURGITATION$553,312
R01 · FY2001 · HL